US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 2, 2015 (11 years ago)

Nandrolone Decanoate 200 mg/ml Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

What was recalled

Nandrolone Decanoate 200 mg/ml Injection, ml Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN

Recalling firm
The Compounding Pharmacy of America
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1616-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Nandrolone recalls

See all
Class II · Moderate risk Ongoing

Nandrolone Decanoate 200mg/mL

Reason Lack of Assurance of Sterility

TMC Acquisition LLC dba Tailor Made Compounding D-1220-2022
Class III · Low risk Terminated

Nandrolone Decanoate

Reason Subpotent Drug

Fagron, Inc NDC 0395-8212-43 D-0866-2022
Class III · Low risk Terminated

Nandrolone Decanoate

Reason Subpotent Drug

Fagron, Inc NDC 0395-8212-56 D-0865-2022
Class III · Low risk Terminated

Nandrolone Decanoate

Reason Subpotent Drug

Fagron, Inc NDC 51552-1564-07 D-0864-2022
Class III · Low risk Terminated

Nandrolone Decanoate

Reason Subpotent Drug

Fagron, Inc NDC 51552-1564-05 D-0863-2022